Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer
Clinical trial NCT03346811 · UNKNOWN
Trial details
- NCT number
- NCT03346811
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-18
- Primary completion
- 2019-05-10
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.